Biogen CEO to step down; drugmaker pulls back on Alzheimer’s drug Aduhelm
Might 3 (Reuters) - Biogen Inc (BIIB.O) mentioned on Tuesday that chief govt Michel Vounatsos will step down and that ...
Thursday, March 6, 2025
Tag: Aduhelm
Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
Biogen said on Tuesday that it might exchange its chief govt and successfully hand over on advertising a high-profile Alzheimer’s ...
CMS’s Decision To Restrict Coverage Of Aduhelm Very Unlikely To Impact Other Accelerated Approvals In Other Classes
WASHINGTON, DC - APRIL 25: Facilities for Medicare and Medicaid Providers Administrator Chiquita ... Brooks-LaSure participates within the American Hospital ...
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Ever since Medicare proposed to sharply restrict protection of the controversial Alzheimer’s drug Aduhelm, the company has been deluged with ...